Cancer Research Cancer Research Funding Available  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossiter, H.
Right arrow Articles by Kupper, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossiter, H.
Right arrow Articles by Kupper, T. S.
[Cancer Research 61, 3619-3626, May 1, 2001]
© 2001 American Association for Cancer Research


Carcinogenesis

Targeted Expression of bcl-2 to Murine Basal Epidermal Keratinocytes Results in Paradoxical Retardation of Ultraviolet- and Chemical-induced Tumorigenesis1

Heidemarie Rossiter, Stefan Beissert, Christoph Mayer, Michael P. Schön, B. Gregor Wienrich, Erwin Tschachler and Thomas S. Kupper2

Department of Dermatology, University of Vienna Medical School, Vienna, A-1090, Austria [H. R., C. M., E. T.]; Department of Dermatology, University of Münster, Münster, Germany [S. B.]; Department of Dermatology and Venerology, Otto-von-Guericke University, Magdeburg, Germany [M. P. S.]; Department of Dermatology, Heinrich-Heine-University, Düsseldorf, Germany [B. G. W.]; Centre de Recherches et d’Investigations Epidermiques et Sensorielles, Neuilly, France [E. T.]; and Department of Dermatology, Brigham and Women’s Hospital, Harvard Institutes of Medicine, Boston, Massachusetts 02115 [T. S. K.]

The antiapoptotic protein bcl-2 is found up-regulated in a number of malignant and premalignant skin conditions of keratinocyte origin, but in normal skin, it is expressed at low levels only in interfollicular epidermis. To investigate whether unregulated bcl-2 expression could affect the incidence of epidermal tumors, we have generated a mouse line that over-expresses human bcl-2 in the basal layer of epidermis under the control of the human keratin 14 promoter. These mice were subjected to both UVB photocarcinogenesis and classical two-stage chemical carcinogenesis. Although transgenic bcl-2 in these mice reduces the formation of sunburn cells after short-term UVB irradiation, chronically UVB irradiated K14/bcl-2 mice were protected against tumor development, because transgenic mice developed tumors much later and at a significantly lower frequency than controls. Immunohistochemical analyses of the UVB-induced tumors revealed no significant differences in the degree of inflammatory cell infiltrates. When either K14/bcl-2 mice or F1 progeny of matings with mice expressing an activated Ha-ras oncogene (K14/bcl-2/ras) were treated with 9,10-dimethyl-1,2-benzanthracene/phorbol 12-myristate 13-acetate, the latency of first papilloma appearance was the same in transgenic mice and controls, but further papillomas developed more slowly in the mutant mice. Moreover, the K14/bcl-2/ras mice developed far fewer albeit larger tumors/mouse than did the ras/+ controls. The rate of conversion to malignant carcinomas, the carcinoma grade, and the frequency of lymph node metastases were not significantly different between mutants and controls. We conclude that, despite its antiapoptotic function, bcl-2, overexpressed in basal epidermal keratinocytes, exerts a paradoxical retardation on the development of skin tumors induced by chemical carcinogens and particularly by UVB.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
H. He, Q. Gu, M. Zheng, D. Normolle, and Y. Sun
SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27
Carcinogenesis, April 1, 2008; 29(4): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Zhang, A. N. Hanks, K. Boucher, S. R. Florell, S. M. Allen, A. Alexander, D. E. Brash, and D. Grossman
UVB-induced apoptosis drives clonal expansion during skin tumor development
Carcinogenesis, January 1, 2005; 26(1): 249 - 257.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Macdiarmid, D. Stevenson, D. H. Campbell, and J. B. Wilson
The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo
Carcinogenesis, July 1, 2003; 24(7): 1209 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Allen, S. R. Florell, A. N. Hanks, A. Alexander, M. J. Diedrich, D. C. Altieri, and D. Grossman
Survivin Expression in Mouse Skin Prevents Papilloma Regression and Promotes Chemical-induced Tumor Progression
Cancer Res., February 1, 2003; 63(3): 567 - 572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Sitailo, S. S. Tibudan, and M. F. Denning
Activation of Caspase-9 Is Required for UV-induced Apoptosis of Human Keratinocytes
J. Biol. Chem., May 24, 2002; 277(22): 19346 - 19352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.